In melanoma and other cancers, TGF-β and associated miRNAs such as miR-183 and miR-1245 create an NK cell phenotype that can no longer effectively attack tumor cells, contributing to the immune equilibrium where NK cells are present but not fully functional. This evidence concerns the gene TGFB1 and cancer.